Pharma TM Articles

GLP-1 weight-loss medications like Wegovy, Mounjaro and Ozempic have seen explosive growth in both NHS and private healthcare settings, with over four million prescriptions dispensed in 2025/26 alone. As millions more UK adults plan to start treatment and online providers proliferate, healthcare professionals face mounting exposure to clinical negligence claims arising from inadequate assessment, consent processes, and patient monitoring. What are the key risk factors driving potential litigation, and how c

Parliament is set to debate a reintroduced Bill on assisted dying that would allow terminally ill adults in England and Wales with six months or less to live to request assistance to end their own lives. The legislation includes key amendments addressing terminal illness definitions and the appointment of a Voluntary Assisted Dying Commissioner, while an expert group has raised concerns about capacity, consent, and safeguarding provisions.

Pregnancy after stillbirth brings a complex mix of hope, grief, and anxiety. This guide explores what to expect during a subsequent pregnancy, from increased medical monitoring and emotional challenges to the additional antenatal care designed to support both mother and baby through this deeply personal journey.

The UK Government has introduced sweeping reforms to the regulatory framework governing medicines and medical devices through amendments to the Health Bill currently progressing through Parliament. These proposed changes would grant the Secretary of State new powers to establish a licensing regime for medical devices and enable faster regulatory updates in response to scientific and technological advances.

The UK Government has set out to reform the way that healthcare professional regulators work to modernise and bring the regulatory system up to date. As part of the plans to reform, the General Medical Council (GMC) became a multiprofessional regulator responsible for the regulation of physician associates (PAs) and anesthesia associates (Aas) from December 2024.

NHS England and the Department of Health and Social Care have unveiled a 10-year vision to transform sepsis management through a new Modern Service Framework. This article examines whether standardised protocols and screening tools represent genuine progress in patient safety, or if there's a risk that clinical judgement and patient voices could be overshadowed by tick-box medicine in managing this time-critical medical emergency.

The UK's new Managing Sepsis Framework aims to standardize sepsis care through improved data gathering, clearer guidelines, and better clinical systems. But can checklists and protocols truly replace clinical judgment when recognizing this life-threatening condition, and will the framework address the critical importance of listening to patients and families who know when something is seriously wrong?

Police in England have today announced the trial of what is believed to be the world’s first roadside breathalyser designed specifically to detect nitrous oxide, more commonly known as “laughing gas”. For anyone concerned about drug driving investigations, this represents a significant development and could mark a turning point in how these cases are investigated and prosecuted.

In Part 1, I looked at why sepsis remains such a difficult clinical emergency to recognise and respond to. In this second part, I consider the new Modern Service Framework for sepsis and whether it represents a genuine opportunity to improve patient safety.

NHS England's new Sepsis Modern Service Framework sets out an ambitious 10-year plan to reduce deaths and complications from sepsis by 25% by 2035. With over 133,000 hospital admissions and 1,300 clinical negligence claims related to sepsis in recent years, understanding the warning signs and knowing when delays in diagnosis may constitute medical negligence has never been more critical.